| 前收盘价格 | 0.039 |
| 收盘价格 | 0.039 |
| 成交量 | 7,632,703 |
| 平均成交量 (3个月) | 4,309,804 |
| 市值 | 91,216,808 |
| 价格/销量 (P/S) | 3.12 |
| 股市价格/股市净资产 (P/B) | 6.71 |
| 52周波幅 | |
| 利润日期 | 28 Jul 2025 - 1 Aug 2025 |
| 营业毛利率 | 12.91% |
| 营业利益率 (TTM) | 28.63% |
| 季度收入增长率 (YOY) | 157.50% |
| 总债务/股东权益 (D/E MRQ) | 25.23% |
| 流动比率 (MRQ) | 1.73 |
| 营业现金流 (OCF TTM) | 1.61 M |
| 杠杆自由现金流 (LFCF TTM) | -2.61 M |
| 资产报酬率 (ROA TTM) | 18.73% |
| 股东权益报酬率 (ROE TTM) | 51.99% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Packaged Foods (AU) | 混合的 | 混合的 |
| Packaged Foods (全球的) | 混合的 | 看跌 | |
| 股票 | BIOXYNE FPO [BXN] | - | - |
AIStockmoo 评分
0.5
| 分析师共识 | 0.0 |
| 内部交易活动 | NA |
| 价格波动 | 2.0 |
| 技术平均移动指标 | 1.0 |
| 技术振荡指标 | -1.0 |
| 平均 | 0.50 |
|
Bioxyne Ltd is an Australian life science and health products company. The company is engaged in the development, manufacture, and distribution of consumer dietary supplements based on the proprietary probiotic strain of Lactobacillus fermentum PCC. Some of its products include Breathe Life Science, Dr Watson, BLS Clinics, Mirai Solution, CanXChange, and others. The company operates in segments namely, wholesale sales, Plant-based, Manufacturing sales, and direct sales. The majority of the revenue is generated from plants based segment. |
|
| 部门 | Consumer Defensive |
| 行业 | Packaged Foods |
| 投资方式 | Small Growth |
| 内部持股比例 | 74.15% |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合